Fuloria Shivkanya, Subramaniyan Vetriselvan, Gupta Gaurav, Sekar Mahendran, Meenakshi Dhanalekshmi Unnikrishnan, Sathasivam Kathiresan, Sudhakar Kalvatala, Alharbi Khalid Saad, Almutairi Sultan Saadi, Almalki Waleed Hassan, Fuloria Neeraj Kumar
Faculty of Pharmacy /Centre of Excellence for Biomaterials Engineering, AIMST University, Kedah 08100, Malaysia.
Faculty of Medicine, Bioscience and Nursing, MAHSA University, Bandar Saujana Putra, 42610 Jenjarom Selangor, Malaysia.
J Environ Pathol Toxicol Oncol. 2023;42(3):1-29. doi: 10.1615/JEnvironPatholToxicolOncol.2022044456.
Technological advancement to enhance tumor cells (TC) has allowed discovery of various cellular bio-markers: cancer stem cells (CSC), circulating tumor cells (CTC), and endothelial progenitor cells (EPC). These are responsible for resistance, metastasis, and premetastatic conditions of cancer. Detection of CSC, CTC, and EPC assists in early diagnosis, recurrence prediction, and treatment efficacy. This review describes various methods to detect TC subpopulations such as in vivo assays (sphere-forming, serial dilution, and serial transplantation), in vitro assays (colony-forming cells, microsphere, side-population, surface antigen staining, aldehyde dehydrogenase activity, and Paul Karl Horan label-retaining cells, surface markers, nonenriched and enriched detection), reporter systems, and other analytical methods (flow cytometry, fluorescence microscopy/spectroscopy, etc.). The detailed information on methods to detect CSC, CTC, and EPC in this review will assist investigators in successful prognosis, diagnosis, and cancer treatment with greater ease.
用于增强肿瘤细胞(TC)的技术进步使得发现了各种细胞生物标志物:癌症干细胞(CSC)、循环肿瘤细胞(CTC)和内皮祖细胞(EPC)。这些细胞与癌症的耐药性、转移及转移前状态有关。检测CSC、CTC和EPC有助于早期诊断、复发预测及治疗效果评估。本综述描述了检测TC亚群的各种方法,如体内试验(成球试验、连续稀释和连续移植)、体外试验(集落形成细胞、微球、侧群细胞、表面抗原染色、醛脱氢酶活性及保罗·卡尔·霍兰标记保留细胞、表面标志物、非富集和富集检测)、报告系统及其他分析方法(流式细胞术、荧光显微镜/光谱等)。本综述中关于检测CSC、CTC和EPC方法的详细信息将有助于研究人员更轻松地成功进行预后、诊断及癌症治疗。